ITGB1 antibody
Quick Overview for ITGB1 antibody (ABIN7670178)
Target
See all ITGB1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- AF/LE Purified Anti-Human CD29 Antibody[TS2/16.2.1]
-
Endotoxin Level
- Low Endotoxin
-
Immunogen
- E-AB-F097930
-
Isotype
- IgG1, kappa
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- ≥ 1 mg/mL
-
Buffer
- Sterile PBS. < 1.0 EU per mg of the antibody as determined by the LAL method.
-
Preservative
- Azide free
-
Handling Advice
- avoid freeze / thaw cycles. This preparation contains no preservatives, thus it should be handled under aseptic conditions.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store at 4°C valid for 12 months or -20°C valid for long term storage, avoid freeze / thaw cycles. This preparation contains no preservatives, thus it should be handled under aseptic conditions.
-
Expiry Date
- 12 months
-
-
- ITGB1 (Integrin beta 1 (ITGB1))
-
Alternative Name
- CD29
-
Background
- Integrin beta-1,ITB1,Itgb1,Fibronectin receptor subunit beta,VLA-4 subunit beta,CD29,CD29 is a 130 kD single chain type I glycoprotein also known as integrin β1, VLA-β chain, or gpIIa. It is broadly expressed on a majority of hematopoietic and non-hematopoietic cells, including leukocytes (although at low level on granulocytes), platelets, fibroblasts, endothelial cells, epithelial cells, and mast cells. CD29 is a member of the integrin family. It is non-covalently associated with integrin α1-α6 chains to form VLA-1 to VLA-6 Molecules, respectively. Integrins, which include CD29, bind to several cell surface (e.g. VCAM-1, MadCAM-1) and extracellular matrix molecules. CD29 acts as a fibronectin receptor and is involved in a variety of cell-cell and cell-matrix interactions.
-
UniProt
- P05556
-
Pathways
- Cell-Cell Junction Organization, Regulation of G-Protein Coupled Receptor Protein Signaling, CXCR4-mediated Signaling Events, Signaling of Hepatocyte Growth Factor Receptor, Integrin Complex, SARS-CoV-2 Protein Interactome
Target
-